<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4412">
  <stage>Registered</stage>
  <submitdate>22/04/2014</submitdate>
  <approvaldate>22/04/2014</approvaldate>
  <nctid>NCT02122393</nctid>
  <trial_identification>
    <studytitle>A Randomised Trial of Sertraline, Cognitive Behaviour Therapy &amp; Combined Therapy for Postnatal Depression</studytitle>
    <scientifictitle>A Randomised, Controlled Evaluation of Sertraline, Cognitive Behaviour Therapy &amp; Combined Therapy for Postnatal Depression</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>H2001/01263</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Depression</healthcondition>
    <healthcondition>Anxiety</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Depression</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Childbirth and postnatal care</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Sertraline
Behaviour - Cognitive Behavioural Therapy

Active Comparator: Sertraline - 

Active Comparator: Cognitive Behavioural Therapy - 

Active Comparator: Combined Therapy - 


Treatment: drugs: Sertraline


Behaviour: Cognitive Behavioural Therapy


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
    <interventioncode>Behaviour</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Beck Depression Inventory</outcome>
      <timepoint>24 weeks</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Beck Anxiety Inventory</outcome>
      <timepoint>24 weeks</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Parenting Stress Index</outcome>
      <timepoint>24 weeks</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Women with an infant &gt; 2 months and &lt; 8 months of age

          -  Infant born after a full-term pregnancy

          -  Infant born with no congenital abnormalities

          -  Diagnosis of depression with postnatal onset according to the Diagnostic and
             Statistical Manual of Mental Disorders 4th Edition (DSM-IV).</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Female</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  positive serum pregnancy test;

          -  concurrent psychiatric disorder (excepting co-morbid anxiety);

          -  recent history of antidepressant usage (within the last month);

          -  history of major allergy or drug allergy;

          -  history of substance abuse;

          -  prior non-response to sertraline, or prior non-response to adequate trials of two
             selective serotonin reuptake inhibitors (SSRIs);

          -  predisposition to headache, migraine or nausea;

          -  tobacco habit in excess of 10 cigarettes per day;

          -  caffeine consumption in excess of 6 cups of coffee/tea or cola-flavoured drinks per
             day;

          -  ongoing dental work;

          -  extreme levels of depression (psychotic);

          -  suicidal intent;

          -  participation in any medical trial within the previous three months;</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3>The people assessing the outcomes</masking3>
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/04/2002</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>45</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/04/2005</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Austin Health - Melbourne</hospital>
    <postcode>3081 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>University of Melbourne</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Commercial sector/Industry</othercollaboratortype>
      <othercollaboratorname>Pfizer</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Th purpose of this study is to determine whether dual psychological and pharmacological
      treatment is superior to either mono-therapy alone in the treatment of postnatal depression.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02122393</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Jeannette Milgrom, PhD</name>
      <address>University of Melbourne</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>